Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

Decitabine-Intensified Modified Busulfan/Cyclophosphamide Conditioning Regimen Improves Survival in Acute Myeloid Leukemia Patients Undergoing Related Donor Hematopoietic Stem Cell Transplantation: A Propensity Score Matched Analysis

To identify the benefit of decitabine (Dec)-intensified myeloablative conditioning on the outcomes of patients with acute myeloid leukemia (AML) after related donor hematopoietic stem cell transplantation (HSCT), we performed a retrospective matched‐pair study from a pool of 156 patients to evaluate...

Full description

Bibliographic Details
Main Authors: Ziying Li, Wei Shi, Xuan Lu, Hui Lu, Xiena Cao, Liang Tang, Han Yan, Zhaodong Zhong, Yong You, Linghui Xia, Yu Hu, Huafang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
decitabine
busulfan
cyclophosphamide
acute myeloid leukemia
related donor hematopoietic stem cell transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.844937/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.844937/full

Similar Items